Loading clinical trials...
Loading clinical trials...
Consolidative Use of Radiotherapy to Block Oligoprogression in Patients With Metastatic Non-Small-Cell Lung Cancer on Tyrosine Kinase Inhibitor
Conditions
Interventions
Radiotherapy
Radiotherapy
Locations
1
Canada
Radiation Medicine Program, Princess Margaret Cancer Centre, University Health Network
Toronto, Ontario, Canada
Start Date
April 1, 2026
Primary Completion Date
April 1, 2028
Completion Date
April 1, 2028
Last Updated
March 4, 2026
NCT07112170
NCT06925984
NCT07363811
NCT05403385
NCT07020065
Lead Sponsor
University Health Network, Toronto
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions